| Schedule of Condensed Balance Sheets |
(a) Condensed Balance Sheets | | | As of December 31, | | | | | 2024 | | | 2025 | | | | | RMB | | | RMB | | | USD | | | | | | | | | | | | | | ASSETS | | | | | | | | | | | Current assets | | | | | | | | | | | Cash | | | 129 | | | | 106,297 | | | | 15,200 | | | Amounts due from related parties | | | 3,436 | | | | 3,357 | | | | 480 | | | Due from shareholders | | | - | | | | 256,794 | | | | 36,721 | | | Intercompany receivable from WFOE | | | 31,014 | | | | 30,300 | | | | 4,333 | | | Prepayments and other current assets | | | 10,960 | | | | 6,827 | | | | 976 | | | Total current assets | | | 45,539 | | | | 403,575 | | | | 57,710 | | | Total assets | | | 45,539 | | | | 403,575 | | | | 57,710 | | | | | | | | | | | | | | | | | LIABILITIES AND SHAREHOLDERS’ DEFICIT | | | | | | | | | | | | | | Current liabilities | | | | | | | | | | | | | | Convertible notes payable | | | — | | | | 18,449 | | | | 2,638 | | | Financial liabilities | | | 20,990 | | | | 24,949 | | | | 3,567 | | | Shareholder loans, at amortized cost | | | 1,078 | | | | 1,053 | | | | 151 | | | Amounts due to related parties | | | 3,594 | | | | 3,511 | | | | 502 | | | Intercompany payable to VIE | | | 5,394 | | | | 5,394 | | | | 771 | | | Accrued expenses and other current liabilities | | | 15,531 | | | | 24,390 | | | | 3,488 | | | Total current liabilities | | | 46,587 | | | | 77,746 | | | | 11,117 | | | Investments in subsidiaries | | | 433,592 | | | | 488,047 | | | | 69,788 | | | Total non-current liabilities | | | 433,592 | | | | 488,047 | | | | 69,788 | | | Total liabilities | | | 480,179 | | | | 565,793 | | | | 80,905 | | | Commitments and Contingencies | | | | | | | | | | | | | | Mezzanine equity*: | | | | | | | | | | | | | | Series A Redeemable Convertible Preferred Shares (US$0.00001 par value: 387,781,378 shares authorized as at December 31, 2024 and December 31, 2025, Redemption value of RMB56,098 and nil as of December 31, 2024 and 2025, respectively) | | | 56,098 | | | | — | | | | — | | | Series B Redeemable Convertible Preferred Shares (US$0.00001 par value: 703,901,412 shares authorized as at December 31, 2024 and December 31, 2025, Redemption value of RMB787,739 and nil as of December 31, 2024 and 2025, respectively) | | | 787,739 | | | | — | | | | — | | | Series C Redeemable Convertible Preferred Shares (US$0.00001 par value: 517,022,352 shares authorized as at December 31, 2024 and December 31, 2025, Redemption value of RMB181,992 and nil as of December 31, 2024 and 2025, respectively) | | | 181,992 | | | | — | | | | — | | | Series C-1 Redeemable Convertible Preferred Shares (US$0.00001 par value: 357,323,044 shares authorized as at December 31, 2024 and December 31, 2025, Redemption value of RMB153,660 and nil as of December 31, 2024 and 2025, respectively) | | | 153,660 | | | | — | | | | — | | | Series C-2 Redeemable Convertible Preferred Shares (US$0.00001 par value: 220,757,061 shares authorized as at December 31, 2024 and December 31, 2025, Redemption value of RMB189,973 and nil as of December 31, 2024 and 2025, respectively) | | | 189,873 | | | | — | | | | — | | | Series D Redeemable Convertible Preferred Shares (US$0.00001 par value: 95,320,147 shares authorized as at December 31, 2024 and December 31, 2025, Redemption value of RMB136,115 and nil as of December 31, 2024 and 2025, respectively) | | | 136,115 | | | | — | | | | — | | | Subscription receivable from Series B Redeemable Convertible Preferred Shares | | | (134,455 | ) | | | — | | | | — | | | Subscription receivable from Series C Redeemable Convertible Preferred Shares | | | (29,026 | ) | | | — | | | | — | | | Subscription receivable from Series C-1 Redeemable Convertible Preferred Shares | | | (38,955 | ) | | | — | | | | — | | | Total mezzanine equity | | | 1,303,041 | | | | — | | | | — | | | | | As of December 31, | | | | | 2024 | | | 2025 | | | | | RMB | | | RMB | | | USD | | | | | | | | | | | | | | SHAREHOLDERS’ DEFICIT | | | | | | | | | | | Class A ordinary shares (US$0.00001 par value, 16,000,000,000 shares authorized, 460,147,059 and 2,516,653,606 shares issued and outstanding as of December 31, 2024 and 2025, respectively)* | | | 31 | | | | 177 | | | | 26 | | | Class B ordinary shares (US$0.00001 par value, 800,000,000 shares authorized, nil and 2,516,653,606 shares issued and outstanding as of December 31, 2024 and 2025, respectively)* | | | — | | | | 24 | | | | 3 | | | Additional paid – in capital | | | 47,006 | | | | 1,668,465 | | | | 238,588 | | | Accumulated other comprehensive loss | | | (99,395 | ) | | | (97,912 | ) | | | (14,001 | ) | | Accumulated deficit | | | (1,715,536 | ) | | | (1,762,180 | ) | | | (251,988 | ) | | Total shareholders’ deficit attributable to ordinary shareholders of Yimutian Inc. | | | (1,767,894 | ) | | | (191,426 | ) | | | (27,372 | ) | | Non-controlling interests | | | 30,213 | | | | 29,208 | | | | 4,177 | | | Total shareholders’ deficit | | | (1,737,681 | ) | | | (162,218 | ) | | | (23,195 | ) | | Total liabilities and shareholders’ deficit | | | 45,539 | | | | 403,575 | | | | 57,710 | |
|